Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor

Details for Australian Patent Application No. 2007331663 (hide)

Owner NeuroNova AB

Inventors Zachrisson, Olof; Bertilsson, Goran; Wikstrom, Lilian; Patrone, Cesare; Mercer, Alex; Lindquist, Per

Agent Cullen & Co

Pub. Number AU-A-2007331663

PCT Pub. Number WO2008/071438

Priority 60/875,140 14.12.06 DE

Filing date 14 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61K 31/00 (2006.01)

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/071438 Priority application(s): WO2008/071438

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331664-A cardiopulmonary resuscitation compression force indicator

2007331596-Polypeptides specific for complexes involved in receptor-mediated signaling, such as the IL-6/IL-6 receptor complex